

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Evolution of blood pressure management in acute... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2035/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2035" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Evolution of blood pressure management in acute intracerebral hemorrhage" />
    
            <meta name="og:title" content="F1000Research Article: Evolution of blood pressure management in acute intracerebral hemorrhage.">
            <meta name="og:description" content="Read the latest article version by Stacy Chu, Lauren Sansing, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="12626">
            <meta name="article-id" content="11687">
            <meta name="dc.title" content="Evolution of blood pressure management in acute intracerebral hemorrhage">
            <meta name="dc.description" content="Intracerebral hemorrhage (ICH) remains a prevalent and severe cause of death and disability worldwide. Control of the hypertensive response in acute ICH has been a mainstay of ICH management, yet the optimal approaches and the yield of recommended strategies have been difficult to establish despite a large body of literature. Over the years, theoretical and observed risks and benefits of intensive blood pressure reduction in ICH have been studied in the form of animal models, radiographic studies, and two recent large, randomized patient trials. In this article, we review the historical and developing data and discuss remaining questions surrounding blood pressure management in acute ICH.">
            <meta name="dc.subject" content="intracerebral hemorrhage, hypertension, stroke">
            <meta name="dc.creator" content="Chu, Stacy">
            <meta name="dc.creator" content="Sansing, Lauren">
            <meta name="dc.date" content="2017/11/21">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.11687.1">
            <meta name="dc.source" content="F1000Research 2017 6:2035">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="intracerebral hemorrhage">
            <meta name="prism.keyword" content="hypertension">
            <meta name="prism.keyword" content="stroke">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/11/21">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2035">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.11687.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2035">
            <meta name="citation_title" content="Evolution of blood pressure management in acute intracerebral hemorrhage">
            <meta name="citation_abstract" content="Intracerebral hemorrhage (ICH) remains a prevalent and severe cause of death and disability worldwide. Control of the hypertensive response in acute ICH has been a mainstay of ICH management, yet the optimal approaches and the yield of recommended strategies have been difficult to establish despite a large body of literature. Over the years, theoretical and observed risks and benefits of intensive blood pressure reduction in ICH have been studied in the form of animal models, radiographic studies, and two recent large, randomized patient trials. In this article, we review the historical and developing data and discuss remaining questions surrounding blood pressure management in acute ICH.">
            <meta name="citation_description" content="Intracerebral hemorrhage (ICH) remains a prevalent and severe cause of death and disability worldwide. Control of the hypertensive response in acute ICH has been a mainstay of ICH management, yet the optimal approaches and the yield of recommended strategies have been difficult to establish despite a large body of literature. Over the years, theoretical and observed risks and benefits of intensive blood pressure reduction in ICH have been studied in the form of animal models, radiographic studies, and two recent large, randomized patient trials. In this article, we review the historical and developing data and discuss remaining questions surrounding blood pressure management in acute ICH.">
            <meta name="citation_keywords" content="intracerebral hemorrhage, hypertension, stroke">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Stacy Chu">
            <meta name="citation_author_institution" content="Department of Neurology, Yale School of Medicine, New Haven, CT, USA">
            <meta name="citation_author" content="Lauren Sansing">
            <meta name="citation_author_institution" content="Department of Neurology, Yale School of Medicine, New Haven, CT, USA">
            <meta name="citation_publication_date" content="2017/11/21">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2035">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.11687.1">
            <meta name="citation_firstpage" content="2035">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2035/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2035.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=12626 /> <input type=hidden id=articleId name=articleId value=11687 /> <input type=hidden id=xmlUrl value="/articles/6-2035/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2035-v1.xml"> <input type=hidden id=article_uuid value=81a7bcd9-d18b-4184-96df-7887704749f6 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Evolution of blood pressure management in acute intracerebral hemorrhage"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.11687.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.11687.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2035"
  },
  "headline": "Evolution of blood pressure management in acute intracerebral hemorrhage",
  "datePublished": "2017-11-21T15:20:44",
  "dateModified": "2017-11-21T15:20:44",
  "author": [
    {
      "@type": "Person",
      "name": "Stacy Chu"
    },    {
      "@type": "Person",
      "name": "Lauren Sansing"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Intracerebral hemorrhage (ICH) remains a prevalent and severe cause of death and disability worldwide. Control of the hypertensive response in acute ICH has been a mainstay of ICH management, yet the optimal approaches and the yield of recommended strategies have been difficult to establish despite a large body of literature. Over the years, theoretical and observed risks and benefits of intensive blood pressure reduction in ICH have been studied in the form of animal models, radiographic studies, and two recent large, randomized patient trials. In this article, we review the historical and developing data and discuss remaining questions surrounding blood pressure management in acute ICH."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2035/v1",
            "name": "Evolution of blood pressure management in acute intracerebral hemorrhage"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Evolution of blood pressure management in acute intracerebral hemorrhage </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=12626 data-id=11687 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11687.1" data-recommended="" data-doi="10.12688/f1000research.11687.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2035/v1/pdf?article_uuid=81a7bcd9-d18b-4184-96df-7887704749f6" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-11687-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-11687-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-11687-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Chu S and Sansing L. Evolution of blood pressure management in acute intracerebral hemorrhage [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2035 (<a class=new-orange href="https://doi.org/10.12688/f1000research.11687.1" target=_blank>https://doi.org/10.12688/f1000research.11687.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-11687-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=11687 id=track-article-signin-11687 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11687?target=/articles/6-2035/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12626 /> <input name=articleId type=hidden value=11687 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Evolution of blood pressure management in acute intracerebral hemorrhage</h1><span class=other-info> [version 1; peer review: 4 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Stacy Chu,&nbsp;</span><span class=""><a href="mailto:lauren.sansing@yale.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Lauren Sansing</span></a><a href="https://orcid.org/0000-0002-6898-1680" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6898-1680</div></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Stacy Chu,&nbsp;</span><span class=""><a href="mailto:lauren.sansing@yale.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Lauren Sansing</span></a><a href="http://orcid.org/0000-0002-6898-1680" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-6898-1680</div></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 21 Nov 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.11687.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Neurology, Yale School of Medicine, New Haven, CT, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=27980-27888></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=27978-27886></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=27979-27887></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=27981-27889></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Intracerebral hemorrhage (ICH) remains a prevalent and severe cause of death and disability worldwide. Control of the hypertensive response in acute ICH has been a mainstay of ICH management, yet the optimal approaches and the yield of recommended strategies have been difficult to establish despite a large body of literature. Over the years, theoretical and observed risks and benefits of intensive blood pressure reduction in ICH have been studied in the form of animal models, radiographic studies, and two recent large, randomized patient trials. In this article, we review the historical and developing data and discuss remaining questions surrounding blood pressure management in acute ICH. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> intracerebral hemorrhage, hypertension, stroke </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Lauren Sansing (<a href="mailto:lauren.sansing@yale.edu">lauren.sansing@yale.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Lauren Sansing </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Chu S and Sansing L. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Chu S and Sansing L. Evolution of blood pressure management in acute intracerebral hemorrhage [version 1; peer review: 4 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2035 (<a href="https://doi.org/10.12688/f1000research.11687.1" target=_blank>https://doi.org/10.12688/f1000research.11687.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 21 Nov 2017, <b>6</b>(F1000 Faculty Rev):2035 (<a href="https://doi.org/10.12688/f1000research.11687.1" target=_blank>https://doi.org/10.12688/f1000research.11687.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 21 Nov 2017, <b>6</b>(F1000 Faculty Rev):2035 (<a href="https://doi.org/10.12688/f1000research.11687.1" target=_blank>https://doi.org/10.12688/f1000research.11687.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d72507e152>Introduction</h2><p class="" id=d72507e155>Elevated blood pressure (BP) is prevalent in an estimated 60–84%<sup><a href="#ref-1">1</a>,<a href="#ref-2">2</a></sup> of patients presenting with acute stroke<sup><a href="#ref-2">2</a></sup>. The pathophysiologic mechanisms underlying the acute hypertensive response observed in stroke are not clearly understood, although proposed theories have included autoregulation to improve cerebral perfusion, Cushing reflex in patients with elevated intracranial pressure (ICP), damage to brain areas regulating BP<sup><a href="#ref-3">3</a></sup>, and a sympathetic response to discomfort or illness<sup><a href="#ref-4">4</a></sup>. It is also reasonable to attribute at least a proportion of hypertension in patients with acute stroke to chronic hypertension, although this explanation would be inconsistent with the observed patterns of spontaneous reduction in BPs over the several days following stroke<sup><a href="#ref-1">1</a></sup>. Of stroke subtypes, there is a higher prevalence of severe hypertension among patients with acute intracerebral hemorrhage (ICH)<sup><a href="#ref-2">2</a></sup>. Interestingly, the Oxford Vascular Study found that the mean first systolic blood pressure (SBP) after ICH onset was much higher than the most recent pre-ICH reading, and this difference was greater than that seen in patients with acute ischemic stroke despite similar rates of premorbid hypertension (ICH mean 43.5 mm Hg increase versus ischemic stroke mean 17.9 mm Hg increase, <i>P</i> &lt;0.0001)<sup><a href="#ref-5">5</a></sup>. Additionally, BPs decreased more rapidly in the first 24 hours after ICH than after ischemic stroke (41.4 versus 13.6 mm Hg, <i>P</i> = 0.0007), even after excluding patients who received antihypertensives and who died prior to 24 hours after onset. This suggests that the hypertensive response to ICH is different from other types of brain injury, perhaps due to the mass effect of the hemorrhage or responses to blood vessel rupture or blood products.</p><p class="" id=d72507e196>The clinical significance of hypertension in acute stroke and the optimal strategies for managing it have been topics of extensive study for many decades. Elevated admission BP has been associated with increased mortality and disability among certain groups of stroke patients<sup><a href="#ref-6">6</a>,<a href="#ref-7">7</a></sup> and in particular among patients with ICH<sup><a href="#ref-8">8</a></sup>. A relationship between uncontrolled BP and hematoma volume expansion has been reported in several studies<sup><a href="#ref-9">9</a>–<a href="#ref-11">11</a></sup>; however, others have failed to find a clear association<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. These conflicting data cast doubt on whether it is a simple linear relationship between pressure and hemorrhage growth. There are more consistent data on the association between hematoma growth and poor outcome<sup><a href="#ref-13">13</a>,<a href="#ref-14">14</a></sup>, so that any potential decrease in the risk of expansion attributable to aggressive BP control has therapeutic interest. The management of elevated BP in acute ICH confronts two conflicting pathophysiologic processes. First, BP reduction lowers hydrostatic pressure and therefore may attenuate hematoma expansion and theoretically perihematoma edema as well. Second, there is the potential risk of worsening ischemia in the perihematomal region or precipitating renal injury by aggressively lowering perfusion pressures. In the following paragraphs, we describe the main concerns that have surrounded BP management in acute ICH in recent years, and we summarize the data that have influenced various perspectives on this controversial topic.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d72507e234>Summary of data and recent guidelines</h2><div class=section><a name=d72507e237 class=n-a></a><h3 class=section-title>Safety</h3><p class="" id=d72507e242>Recently, a number of clinical trials have demonstrated the relative safety of BP reduction in acute ICH. However, evidence of therapeutic benefit has remained elusive or variable, and optimal strategies to lower BP are poorly defined. Prior to large clinical trials, caution against aggressive BP treatment came in the form of retrospective data suggesting that rapid BP reduction, as reflected by steeper slopes of the change in mean arterial pressure (MAP) over time, was associated with increased mortality<sup><a href="#ref-15">15</a></sup>. Magnetic resonance imaging (MRI) diffusion and perfusion studies also found hemispheric hypoperfusion and, in some patients, perihematomal areas of decreased apparent diffusion coefficients, which were correlated with poor outcome. If these areas represented risk for secondary ischemia, BP reduction could lead to further neurological injury<sup><a href="#ref-16">16</a></sup>.</p><p class="" id=d72507e253>Despite this concern, early animal studies showed that controlled antihypertensive treatment in the acute period had no adverse effect on ICP or regional cerebral blood flow (CBF), as measured by radiolabeled microspheres<sup><a href="#ref-17">17</a></sup>. Additionally, human radiographic studies of the posited “penumbra” suggested that early BP control in acute ICH could be safe. Positron emission tomography (PET) was used to demonstrate that perihematomal areas of hypoperfusion were characterized by matched reduction in demand, with reduced oxygen metabolism and extraction rather than the increased oxygen extraction seen in ischemia<sup><a href="#ref-18">18</a></sup>. PET was also used to show that the use of antihypertensive medications to lower MAP in the acute period led to no further changes in global or perihematomal blood flow, suggesting preservation of autoregulation despite antihypertensive treatment<sup><a href="#ref-19">19</a></sup>. More recently, similar findings were confirmed by using computed tomography (CT) perfusion imaging in the Intracerebral Hemorrhage Acutely Decreasing Blood Pressure Trial (ICH-ADAPT)<sup><a href="#ref-20">20</a></sup>. Patients presenting with SBP of more than 150 mm Hg and moderately sized ICH within 24 hours of onset were randomly assigned to a target SBP of less than 150 mm Hg or less than 180 mm Hg. There was no difference in perihematomal CBF between groups and no association between magnitude of SBP reduction and perihematomal CBF. In addition, maximum oxygen extraction fraction (OEF[max]) and maximum cerebral metabolic rate of oxygen (CMRO2[max]) were not affected by aggressive SBP treatment<sup><a href="#ref-21">21</a></sup>. Cerebral perfusion pressure was also maintained in the perihematomal region, and the perfusion pressure did not differ by BP treatment arms or BP<sup><a href="#ref-22">22</a></sup>. Information from these studies offered to quiet the theoretical risk of major ischemia in the perihematomal area. However, substantial prospective data were not available at the time.</p><p class="" id=d72507e281>The American Heart Association/American Stroke Association guidelines for management of spontaneous ICH have evolved over the last few iterations, reflecting conclusions drawn from sequential studies on intensive BP treatment. Prior to publication of the 2007 guidelines<sup><a href="#ref-23">23</a></sup>, a prospective trial of 27 patients found a low rate of neurological deterioration and hematoma expansion in patients who received treatment to reduce BP below 160 systolic and 90 diastolic within 24 hours<sup><a href="#ref-24">24</a></sup>. Two clinical trials—the Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage (INTERACT)<sup><a href="#ref-25">25</a></sup> and the Antihypertensive Treatment in Acute Cerebral Hemorrhage (ATACH) study<sup><a href="#ref-26">26</a></sup>—had just begun. In the absence of clinical trial data, guideline recommendations were hesitant, suggesting treatment for BPs over 200 mm Hg systolic or MAP over 150 mm Hg, and discretion to treat BPs over 180 mm Hg systolic or MAP over 130 mm Hg, either to a goal cerebral perfusion pressure of 60–80 mm Hg in patients with elevated ICP or to a target BP 160/90 mm Hg or MAP 110 mm Hg in those not suspected to have elevated ICP<sup><a href="#ref-23">23</a></sup>.</p><p class="" id=d72507e304>In the mid-2000s, a systematic review reported that elevated SBP was associated with more than fivefold odds of subsequent death or deterioration after primary ICH<sup><a href="#ref-27">27</a></sup>. A few years later, a prospective Chinese study of 1,760 patients with ICH reported a direct linear association between elevations in SBP and death and major disability<sup><a href="#ref-28">28</a></sup>. Another retrospective study, of 122 patients with ICH, found an association between BP control and neurological deterioration over the course of 24 hours<sup><a href="#ref-29">29</a></sup>. The risk of neurological deterioration—defined by comparing baseline and 24-hour Glasgow Coma Scale (GCS) scores—was significantly lower in the quartile of patients with maximum SBP drop over the course of 24 hours. These studies further highlighted the need to determine whether intervening in elevated BP could mitigate the poor outcomes seen after acute ICH, and trials ensued (<a href="#T1">Table 1</a>).</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Summary of randomized, prospective clinical trials studying acute blood pressure management in intracerebral hemorrhage.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d72507e334 class=n-a></a><thead><a name=d72507e336 class=n-a></a><tr><a name=d72507e338 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d72507e340 class=n-a></a>Study (year of<br class=br>publication)</th><th align=left colspan=1 rowspan=1 valign=top><a name=d72507e345 class=n-a></a>Patients</th><th align=left colspan=1 rowspan=1 valign=top><a name=d72507e348 class=n-a></a>Number<br class=br>of<br class=br>subjects</th><th align=left colspan=1 rowspan=1 valign=top><a name=d72507e355 class=n-a></a>Intervention</th><th align=left colspan=1 rowspan=1 valign=top><a name=d72507e358 class=n-a></a>Primary outcome</th><th align=left colspan=1 rowspan=1 valign=top><a name=d72507e362 class=n-a></a>Results</th></tr></thead><tbody><a name=d72507e367 class=n-a></a><tr><a name=d72507e369 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e371 class=n-a></a>Rapid blood pressure<br class=br>reduction in acute ICH<br class=br>(2008)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e378 class=n-a></a>Supratentorial ICH<br class=br>within 8 hours of<br class=br>symptom onset</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e385 class=n-a></a>42</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e388 class=n-a></a>MAP &lt;110<br class=br>versus MAP<br class=br>110–130</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e395 class=n-a></a>Decline in NIHSS ≥2<br class=br>points at 48 hours,<br class=br>mRS score ≤2 at 90<br class=br>days, hematoma and<br class=br>edema expansion<br class=br>&gt;30% from baseline<br class=br>volume on 24-hour CT</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e412 class=n-a></a>No significant differences<br class=br>in early neurological<br class=br>deterioration (<i>P</i> = 0.55),<br class=br>hematoma and edema<br class=br>growth (<i>P</i> = 1.0, <i>P</i> = 0.35),<br class=br>and clinical outcome at<br class=br>90 days (<i>P</i> = 0.43).</td></tr><tr><a name=d72507e441 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e443 class=n-a></a>Intensive Blood Pressure<br class=br>Reduction in Acute<br class=br>Cerebral Hemorrhage<br class=br>(INTERACT) (2008)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e452 class=n-a></a>ICH within 6 hours<br class=br>of symptom onset<br class=br>and SBP 150–220</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e459 class=n-a></a>404</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e462 class=n-a></a>SBP &lt;140 versus<br class=br>SBP &lt;180</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e467 class=n-a></a>Proportional change in<br class=br>hematoma volume in<br class=br>24 hours, mRS score<br class=br>of 3–6 at 90 days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e477 class=n-a></a>No excess neurological<br class=br>deterioration or other<br class=br>adverse events in<br class=br>intensively treated group,<br class=br>reduced rate of hematoma<br class=br>growth by 8% (<i>P</i> = 0.05)</td></tr><tr><a name=d72507e495 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e497 class=n-a></a>Antihypertensive<br class=br>Treatment in Acute<br class=br>Cerebral Hemorrhage<br class=br>(ATACH) (2010)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e506 class=n-a></a>Supratentorial ICH<br class=br>within 6 hours of<br class=br>symptom onset and<br class=br>SBP ≥200</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e515 class=n-a></a>60</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e518 class=n-a></a>IV nicardipine,<br class=br>three tiers of<br class=br>SBP:<br class=br>170–200<br class=br>140–170<br class=br>110–140</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e531 class=n-a></a>Neurological<br class=br>deterioration within<br class=br>24 hours, serious<br class=br>adverse events within<br class=br>72 hours</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e543 class=n-a></a>Low rate of serious<br class=br>adverse events and<br class=br>neurological deterioration<br class=br>among all three tiers.<br class=br>No difference in average<br class=br>SBP change between<br class=br>patients with and without<br class=br>neurological deterioration<br class=br>(<i>P</i> = 0.47)</td></tr><tr><a name=d72507e567 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e569 class=n-a></a>Intracerebral Hemorrhage<br class=br>Acutely Decreasing Blood<br class=br>Pressure Trial (ICH-ADAPT)<br class=br>(2013)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e578 class=n-a></a>ICH within 24 hours<br class=br>of symptom onset<br class=br>and SBP ≥150</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e585 class=n-a></a>82</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e588 class=n-a></a>IV labetalol,<br class=br>SBP &lt;150 versus<br class=br>&lt;180</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e595 class=n-a></a>Perihematoma rCBF<br class=br>on CT perfusion,<br class=br>2 hours after treatment</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e603 class=n-a></a>Peri-hematoma rCBF was<br class=br>not lower among patients<br class=br>randomly assigned to<br class=br>SBP &lt;150 (<i>P</i> = 0.18)</td></tr><tr><a name=d72507e616 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e618 class=n-a></a>INTERACT2 (2016)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e621 class=n-a></a>ICH within 6 hours<br class=br>of symptom onset,<br class=br>SBP 150–220</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e628 class=n-a></a>2,794</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e631 class=n-a></a>SBP &lt;140 within<br class=br>1 hours versus<br class=br>SBP &lt;180</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e638 class=n-a></a>Death or mRS score<br class=br>&gt;2 at 90 days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e644 class=n-a></a>No significant change in<br class=br>the rate of death or major<br class=br>disability. Trend toward<br class=br>improved functional<br class=br>outcome on ordinal<br class=br>analysis. OR 0.87 (95% CI<br class=br>0.75–1.01, <i>P</i> = 0.06)</td></tr><tr><a name=d72507e665 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e667 class=n-a></a>ATACH-2 (2016)</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e670 class=n-a></a>Supratentorial ICH<br class=br>within 4.5 hours of<br class=br>symptom onset,<br class=br>SBP ≥180</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e679 class=n-a></a>1,000</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e682 class=n-a></a>SBP 110–139<br class=br>versus SBP<br class=br>140–179</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e689 class=n-a></a>Death or mRS score of<br class=br>4–6 at 90 days</td><td align=left colspan=1 rowspan=1 valign=top><a name=d72507e695 class=n-a></a>No difference in the rate of<br class=br>death or severe disability<br class=br>(<i>P</i> = 0.72). Higher rate<br class=br>of renal complications in<br class=br>7 days among treatment<br class=br>arm (<i>P</i> = 0.002)</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d72507e720 class=n-a></a><p id=d72507e722> Blood pressure is presented in millimeters of mercury (mm Hg). CI, confidence interval; CT, computed tomography; ICH, intracerebral hemorrhage; IV, intravenous; MAP, mean arterial pressure; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; rCBF, relative cerebral blood flow; SBP, systolic blood pressure.</p></div></div></div></div><div class=section><a name=d72507e729 class=n-a></a><h3 class=section-title>Early trials</h3><p class="" id=d72507e734>In 2008, a prospective trial which randomly assigned 21 patients each to groups with target MAP of less than 110 mm Hg versus 110–130 mm Hg found no significant differences between the groups in early neurological deterioration, hematoma and edema growth, and clinical outcome at 90 days<sup><a href="#ref-30">30</a></sup>. Additionally, INTERACT was published in 2008 and provided data in the form of an open-label, randomized controlled trial of 404 patients from China, Australia, and South Korea with CT-confirmed ICH, who had SBP of 150–220 mm Hg and could be assessed and receive treatment within 6 hours of onset. Patients were randomly assigned to target BPs of either SBP of 140 mm Hg within 1 hour to continue for 7 days or SBP of 180 mm Hg in keeping with contemporaneous guidelines. Antihypertensive agents were chosen in concordance with local protocols. Results showed a trend toward attenuation of hematoma growth in the intensive treatment group, without excess neurological deterioration or other adverse events<sup><a href="#ref-25">25</a></sup>. A post-hoc analysis of the trial reported that more intensive SBP reductions in the trial were associated with less hematoma expansion<sup><a href="#ref-31">31</a></sup>. In 2010, the National Institutes of Health–funded multicenter prospective pilot clinical trial ATACH was presented. It included 60 patients who presented within 6 hours of ICH onset, in whom intravenous nicardipine was used to assess three tiers of SBP targets (170–200, 140–170, and 110–140 mm Hg) to be maintained for 24 hours. The 3-month mortality was lower than expected in all tiers, and frequencies of neurological deterioration and serious adverse events were below pre-specified safety thresholds<sup><a href="#ref-26">26</a></sup>. Overall, the pilot demonstrated feasibility and safety of early BP lowering. In a post-hoc analysis, patients who had more aggressive SBP reduction over the course of 24 hours (based on area under the curve of hourly SBP and baseline SBP) showed trends toward reduced hematoma expansion and better 3-month outcomes.<sup><a href="#ref-32">32</a></sup>. Based on this emerging available evidence, guidelines were updated to suggest that lowering SBP to 140 mm Hg in those patients presenting with SBP between 150 and 220 mm Hg was probably safe but underscored the uncertainty of efficacy until larger trials were completed<sup><a href="#ref-33">33</a></sup>.</p><p class="" id=d72507e762>The pilot clinical trial data were accompanied by additional retrospective and prospective observational studies. In 2012, a multicenter prospective study to evaluate the feasibility of intravenous nicardipine to treat hypertension in acute ICH was reported<sup><a href="#ref-34">34</a></sup>. On average, BPs among the 88 participants dropped from 175.4 ± 33.7 mm Hg systolic to 127.4 ± 16.7 mm Hg systolic over 6 hours of infusion. Only three (3.4%) patients had hematoma expansion, and two (2.2%) had neurological deterioration. In 2015, another study found an inverse association between relative SBP reduction (24-hour SBP compared with that on admission) and neurological deterioration (decrease in GCS or National Institutes of Health Stroke Scale scores at 24 hours compared with admission), hematoma expansion (&gt;33% increase), and unfavorable outcome at 3 months (modified Rankin Scale (mRS) score &gt;3)<sup><a href="#ref-35">35</a></sup>.</p></div><div class=section><a name=d72507e774 class=n-a></a><h3 class=section-title>Phase III clinical trials</h3><p class="" id=d72507e779>The phase III INTERACT2 trial, which studied 2,794 patients presenting with SBP between 150 and 220 mm Hg within 6 hours of symptom onset, provided the largest body of evidence on SBP treatment to date. Those randomly assigned to the intensive treatment group had a target SBP of less than 140 mm Hg within 1 hour of randomization and for a duration of 7 days. Intravenous medications were administered per local protocols, and outcomes were assessed blinded to treatment arm. The standard treatment group had a target SBP of less than 180 mm Hg. The intensive treatment group had an odds ratio (OR) of 0.87 (95% confidence interval (CI) 0.75–1.01, <i>P</i> = 0.06) for the primary outcome of death or major disability, defined as an mRS score of more than 2 at 90 days. Although effect on the primary outcome just missed statistical significance, secondary analyses indicated that the intensive treatment group had significantly better functional recovery on an ordinal analysis of mRS scores and better physical and mental health-related quality of life on the European Quality of Life 5 Dimension (EQ-5D) scale<sup><a href="#ref-36">36</a></sup>. There were no safety concerns identified. A post-hoc analysis of INTERACT2 did find that greater reduction in SBP was associated with reduced hematoma growth (13.3 mL for less than 10 mm Hg, 5.0 mL for 10–20 mm Hg, and 3.0 mL for at least 20 mm Hg, <i>P</i> &lt;0.001). In addition, the lowest mean hematoma growth was in patients in the intensive treatment arm who achieved a target SBP at less than 1 hour compared with those patients who achieved target SBP at later time points<sup><a href="#ref-37">37</a></sup>.</p><p class="" id=d72507e796>Interestingly, INTERACT2 did not show a clear relationship between outcome and time from onset to initiation of BP treatment. Of note, only one third of patients achieved the target SBP within 1 hour; half achieved the target in 6 hours. This raises the possibility that the duration of BP control, rather than the rapidity of treatment, contributed to the outcomes. There are also important populations for whom INTERACT2 did not provide data, including patients presenting with SBP of more than 220, larger hematomas, and more severe neurological deficits and patients undergoing decompressive craniectomy. Nevertheless, the trial offered strong evidence that early intensive BP lowering in the studied population did not lead to increased risk of death or serious adverse events. It demonstrated an effect of intensive treatment target on better functional recovery (although this was a secondary endpoint) as well as a trend toward decreased mortality and major disability (primary endpoint). Based on these data, the current American Heart Association guidelines were revised to state that for “ICH patients presenting with SBP between 150 and 220 mm Hg and without contraindication to acute BP treatment, acute lowering of SBP to 140 mm Hg is safe (Class I; Level of Evidence A) and can be effective for improving functional outcome (Class IIa; Level of Evidence B)”<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d72507e803>The most recent data reported are from the ATACH-2 trial<sup><a href="#ref-39">39</a></sup>. This randomized controlled trial enrolled 1,000 patients in the USA, Europe, and Asia who presented with primary supratentorial ICH and initial SBP of more than 180 mm Hg. Patients were initially enrolled within a 3-hour window from symptom onset, but later the window was expanded to 4.5 hours after an analysis found similar prevalence of hematoma expansion within the 3- to 4.5-hour window<sup><a href="#ref-40">40</a></sup>. Patients 18 years or older with a GCS score of 5 or more and hematoma volumes of less than 60 mL on CT scan were eligible. They were randomly assigned to either the intensive treatment group with a goal SBP of 110–139 mm Hg for 24 hours or the standard treatment group with a goal SBP of 140–179 mm Hg. Intravenous nicardipine was used according to a standard protocol: initiation at 5 mg per hour and then an increase by 2.5 mg per hour every 15 minutes as needed to a maximum of 15 mg per hour. After this, if the SBP was still above target, then intravenous labetalol was used (and if it was not available, intravenous diltiazem or urapidil was used).</p><p class="" id=d72507e814>The primary outcome in ATACH-2 was death or moderately severe to severe disability (mRS score &gt;3) at 3 months. The trial was terminated for futility before reaching the proposed enrollment target of 1,280 subjects, which was calculated to identify a 10% difference between groups. Analysis of the first 1,000 subjects recruited showed that the absolute difference in the rate of death and disability was similar between the two treatment groups (38.7% in the intensive treatment group and 37.7% in the standard treatment group; OR 1.04, CI 0.85–1.27). There was also no difference between groups on the ordinal analysis of the mRS score. The rate of hematoma expansion was slightly lower in the intensive treatment group (19% versus 24%, not significant); however, quality-of-life assessment using EQ-5D also did not demonstrate significant difference between the two groups. There was no difference in the rate of serious adverse events within 72 hours between the two groups; however, the rate of non-serious renal adverse events within 7 days was higher in the intensive treatment group (9% versus 4%). In addition, there were higher rates of serious adverse events within 3 months in the intensive treatment group (25.6% versus 20.0% in the standard treatment group; adjusted relative risk 1.30, CI 1.00–1.69, <i>P</i> = 0.05).</p><p class="" id=d72507e821>Not surprisingly, there was a higher proportion of patients with treatment failure in the intensive treatment group than the standard treatment group. Primary treatment failure, defined as not reaching the target SBP within 2 hours after randomization, occurred in 12.2% of patients in the intensive treatment group versus 0.8% of the standard treatment group. Secondary treatment failure was defined as the hourly minimum SBP greater than the target upper limit for two consecutive hours during the period of 2 to 24 hours after randomization. This occurred in 15.6% of patients in the intensive treatment group versus 1.4% in the standard treatment group. The rate of treatment failure leaves open the possibility that a greater outcome effect could have been achieved if more patients had met the treatment goal, although potentially also at the cost of greater rates of adverse events.</p><p class="" id=d72507e824>Recent meta-analyses<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup> of the major clinical trials—including INTERACT 1 and 2, the feasibility and safety study by Koch <i>et al</i>.<sup><a href="#ref-30">30</a></sup>, ICH-ADAPT, and ATACH-2—indicate that intensive BP-lowering treatment is associated with a modest and non-significant trend toward lower 3-month mortality and dependency as well as reduced hematoma expansion. Though non-significant, the observed trend is intriguing. Further study is needed to better understand the biology underlying the relationships between BP reduction, hematoma expansion, and outcome after ICH, which in turn may inform optimal patient selection for intensive BP reduction.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d72507e845>Remaining questions</h2><div class=section><a name=d72507e848 class=n-a></a><h3 class=section-title>Timing, target, and duration of control</h3><p class="" id=d72507e853>The two largest clinical trials—INTERACT2 and ATACH-2—used SBP of less than 180 mm Hg as the standard treatment target, yet the intensity in the intervention arm and the time to achievement of SBP goals differed between the trials. In ATACH-2, the mean minimum SBP values during the first two hours were 128.9 ± 16 mm Hg in the intensive treatment group and 141.1 ± 14.8 mm Hg in the standard treatment group, and 88% of patients met the SBP goal within 2 hours<sup><a href="#ref-39">39</a></sup>. Even in the standard treatment group, BPs remained under 160 mm Hg for the first 24 hours. Interestingly, in INTERACT2, the mean SBP of the intensive treatment group was 150 mm Hg within the first hour (compared with 164 mm Hg in the standard treatment group), and only 30% of patients in the intensive arm of the trial achieved the target SBP level of less than 140 mm Hg within 1 hour<sup><a href="#ref-36">36</a></sup>. Thus, the INTERACT2 trial in effect tested a more moderate approach to control of hypertension than ATACH-2 and showed more promising results on clinical outcomes. Neither trial was designed to inform whether SBP of 140–160 mm Hg would have different outcomes from SBP of 160–180 mm Hg, assuming that target BPs can be achieved and maintained. Subgroup analyses to address outcome differences between groups as defined by their achieved BPs within the range of SBP of 140–180 mm Hg could be informative. In addition, SBP goals were maintained for 7 days in INTERACT2 but for only 24 hours in ATACH-2, raising important questions about optimal timing and duration of BP control and the effects of these variables on patient outcomes.</p><p class="" id=d72507e864>With consideration to the timing of initiation of BP treatment, pre-hospital screening, assessment, and initiation of treatment are of great interest. Two trials have demonstrated the feasibility of executing an ambulance-based, paramedic-initiated randomized controlled trial. In Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST)<sup><a href="#ref-43">43</a></sup>, 14 patients with suspected acute stroke and hypertension were recruited and randomly assigned to a first dose of lisinopril versus placebo; four patients completed 7 days of study treatment. In the Rapid Intervention with Glyceryl Trinitrate in Hypertensive Stroke Trial (RIGHT)<sup><a href="#ref-44">44</a></sup>, 41 of 80 screened patients were enrolled and successfully randomly assigned to transdermal glyceryl trinitrate versus placebo. SBP between the groups was significantly different at 2 hours (<i>P</i> = 0.03), and there was no difference in rates of serious adverse events or death. Pre-hospital identification of definitive ICH, if achievable, could allow further study on the effects of pre-hospital initiation of antihypertensive treatment specifically in this population.</p><p class="" id=d72507e878>The challenges that exist in applying the available data to individual clinical situations are universal. For BP management in ICH, conclusions from the trials must be extrapolated when patients do not fall within the description of the study patient populations. Patients comprising the majority of subjects in the aforementioned studies had small to moderate-sized hematomas, leaving those with large and more severe hemorrhages an understudied population. Over half of participants in both INTERACT2 and ATACH-2 were recruited from Asian countries. However, there were no differences found in treatment effect among Asian versus non-Asian subjects in either study. In terms of intervention, BP parameters and choice of intervention varied among the studies and depended on the resources available to practicing clinicians; thus, conclusions from the different trials may or may not be generalizable.</p></div><div class=section><a name=d72507e882 class=n-a></a><h3 class=section-title>Patient selection issues</h3><p class="" id=d72507e887>The decision to pursue more aggressive treatment may be informed by methods useful for identifying patients most likely to benefit. Identifying those who may be at particular risk of hematoma expansion could sway the approach to treating hypertension. An interesting body of research has focused on the “spot sign”, or the appearance of contrast extravasation on CT angiography, which is thought to represent an area of active bleeding. This effect has been found to be independently associated with hematoma expansion<sup><a href="#ref-45">45</a>,<a href="#ref-46">46</a></sup> and mortality<sup><a href="#ref-47">47</a></sup>. Other studies have highlighted additional radiographic predictors of hematoma growth, including spot sign number<sup><a href="#ref-48">48</a></sup>; the presence of fluid levels, density heterogeneity, and margin irregularity<sup><a href="#ref-49">49</a></sup>; the black hole sign<sup><a href="#ref-50">50</a></sup>; and the blend sign<sup><a href="#ref-51">51</a></sup>. If radiographic predictive features for hematoma expansion prove robust, they may offer a selection tool for early intensive BP treatment. One such study (SCORE-IT) is testing this hypothesis by using the spot sign in the ATACH-2 study<sup><a href="#ref-52">52</a></sup>.</p><p class="" id=d72507e922>Alternatively, neuroimaging may identify patients at risk of cerebral ischemic events with aggressive BP control. There is a growing literature on the occurrence of diffusion-weighted imaging (DWI) lesions, remote from the primary site of injury and delayed from hemorrhage onset, on the MRIs of an estimated 25% of patients with ICH. Mechanistic theories suggest a “stroke-prone” state after hemorrhagic or ischemic stroke, composed of an enhanced thrombotic milieu or impaired hemodynamic regulation (or both) amidst pre-existing vascular pathology, making distant brain regions potentially susceptible to secondary injury in the setting of rapid BP lowering<sup><a href="#ref-53">53</a></sup>. Such DWI lesions have been found to be more prevalent in patients with acute SBP lowering<sup><a href="#ref-53">53</a>,<a href="#ref-54">54</a></sup> and patients with cerebral amyloid angiopathy<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup> and have been associated with poor functional outcomes<sup><a href="#ref-57">57</a></sup>. In an effort to prospectively study the relationship between BP management and DWI lesions after ICH, the ongoing randomized trial ICH ADAPT II will study patients randomly assigned to an SBP target of less than 140 versus less than 180, with MRI performed on days 2, 7, and 30 to assess the impact of hypertensive therapy on DWI lesions, both at 48 hours and cumulatively over 30 and 90 days. Secondary outcomes will include absolute hematoma growth and prediction of DWI lesion incidence as well as mortality, functional outcome, and cognitive status<sup><a href="#ref-58">58</a></sup>. Factors besides acute BP lowering may be associated with DWI lesions, however. A study of 600 patients with primary ICH found DWI lesions in 26.5% of cases, and associated variables after controlling for race/ethnicity, leukocyte count, and acute in-hospital antihypertensive treatment included higher first recorded SBP as well as greater change in MAP, microbleeds, white matter hyperintensity score, and lower age<sup><a href="#ref-59">59</a></sup>. The association of such imaging markers with different pathologies underlying hemorrhage (that is, cerebral amyloid angiopathy versus hypertensive spontaneous ICH) raises an important distinction for patient selection that has been unaddressed thus far. If the risks and benefits of aggressive BP control vary depending on the underlying pathology, that patients with decidedly different etiologies for spontaneous ICH have been studied as one population may account for some of the difficulties finding evidence of therapeutic benefit. Systematic studies using neuroimaging may assist in delineating optimal selection strategies for SBP target in individual patients.</p></div><div class=section><a name=d72507e957 class=n-a></a><h3 class=section-title>Medication selection</h3><p class="" id=d72507e962>Data are even sparser on specific medication selection; one study has compared nitroprusside and nicardipine and found lower rates of mortality among those who received nicardipine<sup><a href="#ref-60">60</a></sup>. However, a small study of nine patients who received nicardipine and were monitored with transcranial Doppler found evidence of paradoxical intracranial vasoconstriction, as characterized by prominent systolic peak and dicrotic notch, pronounced systolic deceleration, and elevated pulsatility index during nicardipine infusion, thus contradicting the expected autoregulatory response to decreasing BP<sup><a href="#ref-61">61</a></sup>. Without a large body of evidence for one agent over another, the most recent guidelines suggest that an agent be chosen on the basis of practicability, pharmacological profile, potential side effects, and cost<sup><a href="#ref-38">38</a></sup>. Relevant to this question are animal studies that have shown that inflammation contributes to secondary injury in ICH, making the various factors involved in promoting inflammatory pathways attractive potential treatment targets<sup><a href="#ref-62">62</a></sup>. There are data to suggest that activation of the sympathetic nervous system leads to increased inflammation<sup><a href="#ref-63">63</a></sup>. Motivated by this concept, an analysis of the placebo-arm patients in a randomized trial testing a potential neuroprotective agent found that the use of anti-adrenergic medications (beta-blockers and alpha[2]-agonists) was shown to be associated with less edema on 72-hour imaging after hemorrhage volume and BP were controlled for<sup><a href="#ref-63">63</a></sup>. In a retrospective study investigating the association of beta-blocker use with mortality among patients in a prospectively collected ICH database, in-patient beta-blocker use was independently associated with reduced rates of in-hospital and 3-month mortality. However, univariate and multivariate analyses comparing outcomes among patients who received beta-blocker therapy versus other antihypertensive classes of medications failed to show any class-specific difference<sup><a href="#ref-64">64</a></sup>. Potential benefits of different classes of medications on other mechanisms of injury have not been extensively studied. Differences in medication classes used in INTERACT2—primarily alpha(1)-antagonist (urapidil), calcium channel antagonists (nicardipine and nimodipine), and mixed alpha- and beta-antagonists (labetalol) and ATACH-2 (nicardipine)—may also have contributed to outcomes, although this remains speculative.</p></div><div class=section><a name=d72507e995 class=n-a></a><h3 class=section-title>Blood pressure variability</h3><p class="" id=d72507e1000>Control of BP variability did emerge from a secondary analysis of INTERACT2 as a priority in management. When serial BP measurements in two phases of treatment (first 24 hours and days 2–7) were analyzed for variability defined as the standard deviation of SBP, categorized into quintiles, a significant linear association was found between variability and the primary outcome of death or major disability at 90 days (OR 1.41, 95% CI 1.05–1.90; <i>P</i> = 0.0167 for the first 24 hours and OR 1.57, 95% CI 1.14–2.17; <i>P</i> = 0.0124 for days 2–7). Similar associations were seen for the secondary outcome of an ordinal shift in mRS score at 90 days<sup><a href="#ref-65">65</a></sup>. The findings were also reported in a retrospective cohort study<sup><a href="#ref-66">66</a></sup>. Another cohort study measured parameters, including diastolic BPs, pulse pressures, and MAPs, and found that higher mean pulse pressures were significantly associated with in-hospital mortality<sup><a href="#ref-67">67</a></sup>. Secondary analyses addressing this same topic in the ATACH-2 population will be of great interest. It may emerge that avoidance of SBP spikes and acute BP troughs is as important as the specific target chosen if not more so. Furthermore, the use of SBP versus MAP in the different trials raises uncertainty as to which would be the better physiologic marker of the biological effects of BP variability in ICH. Further study to characterize not only the optimal measurement target but also the biological correlates of changes in MAP versus SBP could be important to understanding the physiologic mechanisms underlying outcome effects of different approaches to intensive BP management.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d72507e1025>Conclusions</h2><p class="" id=d72507e1028>Research on BP management in acute ICH over years of study has focused on the mechanics of hematoma expansion, perihematomal physiology, mechanisms of secondary injury, and the relationship between BP targets and patient outcomes. Recent trials have offered the needed data on the safety and potential efficacy of moderately aggressive SBP control in acute ICH. However, the precise interactions between patient selection and the timing and duration of different interventions and outcomes remain intriguing and require further definition.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d72507e1034>Abbreviations</h2><p class="" id=d72507e1037>ATACH, Antihypertensive Treatment in Acute Cerebral Hemorrhage; BP, blood pressure; CBF, cerebral blood flow; CI, confidence interval; CT, computed tomography; DWI, diffusion-weighted imaging; EQ-5D, European Quality of Life 5 Dimension; GCS, Glasgow Coma Scale; ICH, intracerebral hemorrhage; ICP, intracranial pressure; INTERACT, Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage; MAP, mean arterial pressure; MRI, magnetic resonance imaging; mRS, modified Rankin Scale; OR, odds ratio; PET, positron emission tomography; SBP, systolic blood pressure.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d72507e1 class=n-a></a><h2 class=main-title id=d72738>Competing interests</h2><p class=metadata-entry><a name=d72507e89 class=n-a></a><p id=d72507e90> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d72507e1 class=n-a></a><h2 class=main-title id=d72740>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d72507e1044 class=n-a></a><h2 class=main-title id=d72507e1046>Acknowledgments</h2><p class="" id=d72507e1049>Research support is provided by the National Institutes of Health/National Institute of Neurological Disorders and Stroke (to Lauren H. Sansing).</p></div><div class=back-section><a name=d72507e1053 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d72961>References</h2><div class="section ref-list"><a name=d72507e1053 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d72507e1060 class=n-a></a>Wallace JD, Levy LL: Blood pressure after stroke. <i>JAMA.</i> 1981; <b>246</b>(19): 2177–80. <a target=xrefwindow id=d72507e1068 href="http://www.ncbi.nlm.nih.gov/pubmed/7289008">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1071 href="http://dx.doi.org/10.1001/jama.1981.03320190035023">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d72507e1080 class=n-a></a>Qureshi AI, Ezzeddine MA, Nasar A, <i> et al.</i>: Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. <i>Am J Emerg Med.</i> 2007; <b>25</b>(1): 32–8. <a target=xrefwindow id=d72507e1091 href="http://www.ncbi.nlm.nih.gov/pubmed/17157679">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1094 href="http://dx.doi.org/10.1016/j.ajem.2006.07.008">Publisher Full Text </a> | <a target=xrefwindow id=d72507e1098 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2443694">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727138465"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1107 class=n-a></a>Majidi S, Suarez JI, Qureshi AI: Management of Acute Hypertensive Response in Intracerebral Hemorrhage Patients After ATACH-2 Trial. <i>Neurocrit Care.</i> 2017; <b>27</b>(2): 249–258. <a target=xrefwindow id=d72507e1115 href="http://www.ncbi.nlm.nih.gov/pubmed/28004328">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1118 href="http://dx.doi.org/10.1007/s12028-016-0341-z">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727138465">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d72507e1131 class=n-a></a>Alqadri SL, Sreenivasan V, Qureshi AI: Acute hypertensive response management in patients with acute stroke. <i>Curr Cardiol Rep.</i> 2013; <b>15</b>(12): 426. <a target=xrefwindow id=d72507e1139 href="http://www.ncbi.nlm.nih.gov/pubmed/24142579">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1142 href="http://dx.doi.org/10.1007/s11886-013-0426-7">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d72507e1151 class=n-a></a>Fischer U, Cooney MT, Bull LM, <i> et al.</i>: Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study. <i>Lancet Neurol.</i> 2014; <b>13</b>(4): 374–84. <a target=xrefwindow id=d72507e1162 href="http://www.ncbi.nlm.nih.gov/pubmed/24582530">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1165 href="http://dx.doi.org/10.1016/S1474-4422(14)70031-6">Publisher Full Text </a> | <a target=xrefwindow id=d72507e1169 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4238109">Free Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d72507e1179 class=n-a></a>Vemmos KN, Tsivgoulis G, Spengos K, <i> et al.</i>: U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. <i>J Intern Med.</i> 2004; <b>255</b>(2): 257–65. <a target=xrefwindow id=d72507e1190 href="http://www.ncbi.nlm.nih.gov/pubmed/14746563">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1193 href="http://dx.doi.org/10.1046/j.1365-2796.2003.01291.x">Publisher Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d72507e1202 class=n-a></a>Carlberg B, Asplund K, Hägg E: The prognostic value of admission blood pressure in patients with acute stroke. <i>Stroke.</i> 1993; <b>24</b>(9): 1372–5. <a target=xrefwindow id=d72507e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/8362433">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1213 href="http://dx.doi.org/10.1161/01.STR.24.9.1372 ">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d72507e1222 class=n-a></a>Terayama Y, Tanahashi N, Fukuuchi Y, <i> et al.</i>: Prognostic value of admission blood pressure in patients with intracerebral hemorrhage. Keio Cooperative Stroke Study. <i>Stroke.</i> 1997; <b>28</b>(6): 1185–8. <a target=xrefwindow id=d72507e1233 href="http://www.ncbi.nlm.nih.gov/pubmed/9183348">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1236 href="http://dx.doi.org/10.1161/01.STR.28.6.1185">Publisher Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d72507e1245 class=n-a></a>Kazui S, Minematsu K, Yamamoto H, <i> et al.</i>: Predisposing factors to enlargement of spontaneous intracerebral hematoma. <i>Stroke.</i> 1997; <b>28</b>(12): 2370–5. <a target=xrefwindow id=d72507e1256 href="http://www.ncbi.nlm.nih.gov/pubmed/9412616">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1259 href="http://dx.doi.org/10.1161/01.STR.28.12.2370">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d72507e1268 class=n-a></a>Maruishi M, Shima T, Okada Y, <i> et al.</i>: Involvement of fluctuating high blood pressure in the enlargement of spontaneous intracerebral hematoma. <i>Neurol Med Chir (Tokyo).</i> 2001; <b>41</b>(6): 300–4; discussion 304–5. <a target=xrefwindow id=d72507e1279 href="http://www.ncbi.nlm.nih.gov/pubmed/11458742">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1282 href="http://dx.doi.org/10.2176/nmc.41.300">Publisher Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d72507e1291 class=n-a></a>Ohwaki K, Yano E, Nagashima H, <i> et al.</i>: Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. <i>Stroke.</i> 2004; <b>35</b>(6): 1364–7. <a target=xrefwindow id=d72507e1302 href="http://www.ncbi.nlm.nih.gov/pubmed/15118169">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1305 href="http://dx.doi.org/10.1161/01.STR.0000128795.38283.4b">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d72507e1315 class=n-a></a>Jauch EC, Lindsell CJ, Adeoye O, <i> et al.</i>: Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. <i>Stroke.</i> 2006; <b>37</b>(8): 2061–5. <a target=xrefwindow id=d72507e1326 href="http://www.ncbi.nlm.nih.gov/pubmed/16794216">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1329 href="http://dx.doi.org/10.1161/01.STR.0000229878.93759.a2">Publisher Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d72507e1338 class=n-a></a>Davis SM, Broderick J, Hennerici M, <i> et al.</i>: Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. <i>Neurology.</i> 2006; <b>66</b>(8): 1175–81. <a target=xrefwindow id=d72507e1349 href="http://www.ncbi.nlm.nih.gov/pubmed/16636233">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1352 href="http://dx.doi.org/10.1212/01.wnl.0000208408.98482.99">Publisher Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d72507e1361 class=n-a></a>Delcourt C, Huang Y, Arima H, <i> et al.</i>: Hematoma growth and outcomes in intracerebral hemorrhage: the INTERACT1 study. <i>Neurology.</i> 2012; <b>79</b>(4): 314–9. <a target=xrefwindow id=d72507e1372 href="http://www.ncbi.nlm.nih.gov/pubmed/22744655">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1375 href="http://dx.doi.org/10.1212/WNL.0b013e318260cbba">Publisher Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d72507e1384 class=n-a></a>Qureshi AI, Bliwise DL, Bliwise NG, <i> et al.</i>: Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. <i>Crit Care Med.</i> 1999; <b>27</b>(3): 480–5. <a target=xrefwindow id=d72507e1395 href="http://www.ncbi.nlm.nih.gov/pubmed/10199525">PubMed Abstract </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d72507e1404 class=n-a></a>Kidwell CS, Saver JL, Mattiello J, <i> et al.</i>: Diffusion-perfusion MR evaluation of perihematomal injury in hyperacute intracerebral hemorrhage. <i>Neurology.</i> 2001; <b>57</b>(9): 1611–7. <a target=xrefwindow id=d72507e1415 href="http://www.ncbi.nlm.nih.gov/pubmed/11706101">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1418 href="http://dx.doi.org/10.1212/WNL.57.9.1611">Publisher Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d72507e1427 class=n-a></a>Qureshi AI, Wilson DA, Hanley DF, <i> et al.</i>: Pharmacologic reduction of mean arterial pressure does not adversely affect regional cerebral blood flow and intracranial pressure in experimental intracerebral hemorrhage. <i>Crit Care Med.</i> 1999; <b>27</b>(5): 965–71. <a target=xrefwindow id=d72507e1438 href="http://www.ncbi.nlm.nih.gov/pubmed/10362421">PubMed Abstract </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d72507e1448 class=n-a></a>Zazulia AR, Diringer MN, Videen TO, <i> et al.</i>: Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. <i>J Cereb Blood Flow Metab.</i> 2001; <b>21</b>(7): 804–10. <a target=xrefwindow id=d72507e1459 href="http://www.ncbi.nlm.nih.gov/pubmed/11435792">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1462 href="http://dx.doi.org/10.1097/00004647-200107000-00005">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d72507e1471 class=n-a></a>Powers WJ, Zazulia AR, Videen TO, <i> et al.</i>: Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. <i>Neurology.</i> 2001; <b>57</b>(1): 18–24. <a target=xrefwindow id=d72507e1482 href="http://www.ncbi.nlm.nih.gov/pubmed/11445622">PubMed Abstract </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717977361"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1491 class=n-a></a>Butcher KS, Jeerakathil T, Hill M, <i> et al.</i>: The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial. <i>Stroke.</i> 2013; <b>44</b>(3): 620–6. <a target=xrefwindow id=d72507e1502 href="http://www.ncbi.nlm.nih.gov/pubmed/23391776">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1505 href="http://dx.doi.org/10.1161/STROKEAHA.111.000188">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717977361">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d72507e1518 class=n-a></a>Kate MP, Hansen MB, Mouridsen K, <i> et al.</i>: Blood pressure reduction does not reduce perihematoma oxygenation: a CT perfusion study. <i>J Cereb Blood Flow Metab.</i> 2014; <b>34</b>(1): 81–6. <a target=xrefwindow id=d72507e1529 href="http://www.ncbi.nlm.nih.gov/pubmed/24045403">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1532 href="http://dx.doi.org/10.1038/jcbfm.2013.164">Publisher Full Text </a> | <a target=xrefwindow id=d72507e1536 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3887345">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d72507e1545 class=n-a></a>Tamm AS, McCourt R, Gould B, <i> et al.</i>: Cerebral Perfusion Pressure is Maintained in Acute Intracerebral Hemorrhage: A CT Perfusion Study. <i>AJNR Am J Neuroradiol.</i> 2016; <b>37</b>(2): 244–51. <a target=xrefwindow id=d72507e1556 href="http://www.ncbi.nlm.nih.gov/pubmed/26450534">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1559 href="http://dx.doi.org/10.3174/ajnr.A4532">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1087891"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1568 class=n-a></a>Broderick J, Connolly S, Feldmann E, <i> et al.</i>: Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. <i>Stroke.</i> 2007; <b>38</b>(6): 2001–23. <a target=xrefwindow id=d72507e1579 href="http://www.ncbi.nlm.nih.gov/pubmed/17478736">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1582 href="http://dx.doi.org/10.1161/STROKEAHA.107.183689">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1087891">F1000 Recommendation</a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d72507e1596 class=n-a></a>Qureshi AI, Mohammad YM, Yahia AM, <i> et al.</i>: A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. <i>J Intensive Care Med.</i> 2005; <b>20</b>(1): 34–42. <a target=xrefwindow id=d72507e1607 href="http://www.ncbi.nlm.nih.gov/pubmed/15665258">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1610 href="http://dx.doi.org/10.1177/0885066604271619">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1108248"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1619 class=n-a></a>Anderson CS, Huang Y, Wang JG, <i> et al.</i>: Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. <i>Lancet Neurol.</i> 2008; <b>7</b>(5): 391–9. <a target=xrefwindow id=d72507e1630 href="http://www.ncbi.nlm.nih.gov/pubmed/18396107">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1633 href="http://dx.doi.org/10.1016/S1474-4422(08)70069-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1108248">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/4502960"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1646 class=n-a></a>Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators: Antihypertensive treatment of acute cerebral hemorrhage. <i>Crit Care Med.</i> 2010; <b>38</b>(2): 637–48. <a target=xrefwindow id=d72507e1654 href="http://www.ncbi.nlm.nih.gov/pubmed/19770736">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1657 href="http://dx.doi.org/10.1097/CCM.0b013e3181b9e1a5">Publisher Full Text </a> | <a target=xrefwindow id=d72507e1660 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5568798">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/4502960">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d72507e1673 class=n-a></a>Willmot M, Leonardi-Bee J, Bath PM: High blood pressure in acute stroke and subsequent outcome: a systematic review. <i>Hypertension.</i> 2004; <b>43</b>(1): 18–24. <a target=xrefwindow id=d72507e1681 href="http://www.ncbi.nlm.nih.gov/pubmed/14662649">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1684 href="http://dx.doi.org/10.1161/01.HYP.0000105052.65787.35">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d72507e1693 class=n-a></a>Zhang Y, Reilly KH, Tong W, <i> et al.</i>: Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. <i>J Hypertens.</i> 2008; <b>26</b>(7): 1446–52. <a target=xrefwindow id=d72507e1704 href="http://www.ncbi.nlm.nih.gov/pubmed/18551022">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1707 href="http://dx.doi.org/10.1097/HJH.0b013e328300a24a">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d72507e1716 class=n-a></a>Suri MF, Suarez JI, Rodrigue TC, <i> et al.</i>: Effect of treatment of elevated blood pressure on neurological deterioration in patients with acute intracerebral hemorrhage. <i>Neurocrit Care.</i> 2008; <b>9</b>(2): 177–82. <a target=xrefwindow id=d72507e1727 href="http://www.ncbi.nlm.nih.gov/pubmed/18506638">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1730 href="http://dx.doi.org/10.1007/s12028-008-9106-7">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/721970192"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1740 class=n-a></a>Koch S, Romano JG, Forteza AM, <i> et al.</i>: Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. <i>Neurocrit Care.</i> 2008; <b>8</b>(3): 316–21. <a target=xrefwindow id=d72507e1751 href="http://www.ncbi.nlm.nih.gov/pubmed/18360781">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1754 href="http://dx.doi.org/10.1007/s12028-008-9085-8">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/721970192">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d72507e1767 class=n-a></a>Arima H, Anderson CS, Wang JG, <i> et al.</i>: Lower treatment blood pressure is associated with greatest reduction in hematoma growth after acute intracerebral hemorrhage. <i>Hypertension.</i> 2010; <b>56</b>(5): 852–8. <a target=xrefwindow id=d72507e1778 href="http://www.ncbi.nlm.nih.gov/pubmed/20823381">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1781 href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.154328">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d72507e1790 class=n-a></a>Qureshi AI, Palesch YY, Martin R, <i> et al.</i>: Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. <i>Arch Neurol.</i> 2010; <b>67</b>(5): 570–6. <a target=xrefwindow id=d72507e1801 href="http://www.ncbi.nlm.nih.gov/pubmed/20457956">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1804 href="http://dx.doi.org/10.1001/archneurol.2010.61">Publisher Full Text </a> | <a target=xrefwindow id=d72507e1808 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5562043">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d72507e1817 class=n-a></a>Morgenstern LB, Hemphill JC 3rd, Anderson C, <i> et al.</i>: Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. <i>Stroke.</i> 2010; <b>41</b>(9): 2108–29. <a target=xrefwindow id=d72507e1828 href="http://www.ncbi.nlm.nih.gov/pubmed/20651276">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1831 href="http://dx.doi.org/10.1161/STR.0b013e3181ec611b">Publisher Full Text </a> | <a target=xrefwindow id=d72507e1835 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4462131">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d72507e1844 class=n-a></a>Hwang SK, Kim JS, Kim JH, <i> et al.</i>: Antihypertensive treatment of acute intracerebral hemorrhage by intravenous nicardipine hydrochloride: prospective multi-center study. <i>J Korean Med Sci.</i> 2012; <b>27</b>(9): 1085–90. <a target=xrefwindow id=d72507e1855 href="http://www.ncbi.nlm.nih.gov/pubmed/22969257">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1858 href="http://dx.doi.org/10.3346/jkms.2012.27.9.1085">Publisher Full Text </a> | <a target=xrefwindow id=d72507e1862 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3429828">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725348970"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1871 class=n-a></a>Sakamoto Y, Koga M, Todo K, <i> et al.</i>: Relative systolic blood pressure reduction and clinical outcomes in hyperacute intracerebral hemorrhage: the SAMURAI-ICH observational study. <i>J Hypertens.</i> 2015; <b>33</b>(5): 1069–73. <a target=xrefwindow id=d72507e1882 href="http://www.ncbi.nlm.nih.gov/pubmed/25668358">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1885 href="http://dx.doi.org/10.1097/HJH.0000000000000512">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725348970">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718013988"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1899 class=n-a></a>Anderson CS, Heeley E, Huang Y, <i> et al.</i>: Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. <i>N Engl J Med.</i> 2013; <b>368</b>(25): 2355–65. <a target=xrefwindow id=d72507e1910 href="http://www.ncbi.nlm.nih.gov/pubmed/23713578">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1913 href="http://dx.doi.org/10.1056/NEJMoa1214609">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718013988">F1000 Recommendation</a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726330921"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1926 class=n-a></a>Carcel C, Wang X, Sato S, <i> et al.</i>: Degree and Timing of Intensive Blood Pressure Lowering on Hematoma Growth in Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial-2 Results. <i>Stroke.</i> 2016; <b>47</b>(6): 1651–3. <a target=xrefwindow id=d72507e1937 href="http://www.ncbi.nlm.nih.gov/pubmed/27143274">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1940 href="http://dx.doi.org/10.1161/STROKEAHA.116.013326">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726330921">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d72507e1953 class=n-a></a>Hemphill JC 3rd, Greenberg SM, Anderson CS, <i> et al.</i>: Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. <i>Stroke.</i> 2015; <b>46</b>(7): 2032–60. <a target=xrefwindow id=d72507e1964 href="http://www.ncbi.nlm.nih.gov/pubmed/26022637">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1967 href="http://dx.doi.org/10.1161/STR.0000000000000069">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726406047"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e1976 class=n-a></a>Qureshi AI, Palesch YY, Barsan WG, <i> et al.</i>: Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. <i>N Engl J Med.</i> 2016; <b>375</b>(11): 1033–43. <a target=xrefwindow id=d72507e1987 href="http://www.ncbi.nlm.nih.gov/pubmed/27276234">PubMed Abstract </a> | <a target=xrefwindow id=d72507e1990 href="http://dx.doi.org/10.1056/NEJMoa1603460">Publisher Full Text </a> | <a target=xrefwindow id=d72507e1994 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5345109">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726406047">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d72507e2007 class=n-a></a>Qureshi A, Palesch Y, ATACH II Investigators: Expansion of recruitment time window in antihypertensive treatment of acute cerebral hemorrhage (ATACH) II trial. <i>J Vasc Interv Neurol.</i> 2012; <b>5</b>(supp): 6–9. <a target=xrefwindow id=d72507e2015 href="http://www.ncbi.nlm.nih.gov/pubmed/23230458">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2018 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3517029">Free Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727371427"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e2027 class=n-a></a>Lattanzi S, Cagnetti C, Provinciali L, <i> et al.</i>: How Should We Lower Blood Pressure after Cerebral Hemorrhage? A Systematic Review and Meta-Analysis. <i>Cerebrovasc Dis.</i> 2017; <b>43</b>(5–6): 207–13. <a target=xrefwindow id=d72507e2038 href="http://www.ncbi.nlm.nih.gov/pubmed/28241129">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2041 href="http://dx.doi.org/10.1159/000462986">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727371427">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727321047"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e2055 class=n-a></a>Boulouis G, Morotti A, Goldstein JN, <i> et al.</i>: Intensive blood pressure lowering in patients with acute intracerebral haemorrhage: clinical outcomes and haemorrhage expansion. Systematic review and meta-analysis of randomised trials. <i>J Neurol Neurosurg Psychiatr.</i> 2017; <b>88</b>(4): 339–45. <a target=xrefwindow id=d72507e2066 href="http://www.ncbi.nlm.nih.gov/pubmed/28214798">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2069 href="http://dx.doi.org/10.1136/jnnp-2016-315346">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727321047">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d72507e2082 class=n-a></a>Shaw L, Price C, McLure S, <i> et al.</i>: Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST): results from the pilot randomised controlled trial. <i>Emerg Med J.</i> 2014; <b>31</b>(12): 994–9. <a target=xrefwindow id=d72507e2093 href="http://www.ncbi.nlm.nih.gov/pubmed/24078198">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2096 href="http://dx.doi.org/10.1136/emermed-2013-202536">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2100 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4251169">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d72507e2109 class=n-a></a>Ankolekar S, Fuller M, Cross I, <i> et al.</i>: Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). <i>Stroke.</i> 2013; <b>44</b>(11): 3120–8. <a target=xrefwindow id=d72507e2120 href="http://www.ncbi.nlm.nih.gov/pubmed/24003041">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2123 href="http://dx.doi.org/10.1161/STROKEAHA.113.001301">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d72507e2132 class=n-a></a>Goldstein JN, Fazen LE, Snider R, <i> et al.</i>: Contrast extravasation on CT angiography predicts hematoma expansion in intracerebral hemorrhage. <i>Neurology.</i> 2007; <b>68</b>(12): 889–94. <a target=xrefwindow id=d72507e2143 href="http://www.ncbi.nlm.nih.gov/pubmed/17372123">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2146 href="http://dx.doi.org/10.1212/01.wnl.0000257087.22852.21">Publisher Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1160266"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e2155 class=n-a></a>Wada R, Aviv RI, Fox AJ, <i> et al.</i>: CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. <i>Stroke.</i> 2007; <b>38</b>(4): 1257–62. <a target=xrefwindow id=d72507e2166 href="http://www.ncbi.nlm.nih.gov/pubmed/17322083">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2169 href="http://dx.doi.org/10.1161/01.STR.0000259633.59404.f3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1160266">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d72507e2182 class=n-a></a>Kim J, Smith A, Hemphill JC 3rd, <i> et al.</i>: Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. <i>AJNR Am J Neuroradiol.</i> 2008; <b>29</b>(3): 520–5. <a target=xrefwindow id=d72507e2193 href="http://www.ncbi.nlm.nih.gov/pubmed/18065505">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2196 href="http://dx.doi.org/10.3174/ajnr.A0859">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d72507e2206 class=n-a></a>Huynh TJ, Demchuk AM, Dowlatshahi D, <i> et al.</i>: Spot sign number is the most important spot sign characteristic for predicting hematoma expansion using first-pass computed tomography angiography: analysis from the PREDICT study. <i>Stroke.</i> 2013; <b>44</b>(4): 972–7. <a target=xrefwindow id=d72507e2217 href="http://www.ncbi.nlm.nih.gov/pubmed/23444309">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2220 href="http://dx.doi.org/10.1161/STROKEAHA.111.000410">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725842256"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e2229 class=n-a></a>Blacquiere D, Demchuk AM, Al-Hazzaa M, <i> et al.</i>: Intracerebral Hematoma Morphologic Appearance on Noncontrast Computed Tomography Predicts Significant Hematoma Expansion. <i>Stroke.</i> 2015; <b>46</b>(11): 3111–6. <a target=xrefwindow id=d72507e2240 href="http://www.ncbi.nlm.nih.gov/pubmed/26451019">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2243 href="http://dx.doi.org/10.1161/STROKEAHA.115.010566">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725842256">F1000 Recommendation</a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726353955"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e2256 class=n-a></a>Li Q, Zhang G, Xiong X, <i> et al.</i>: Black Hole Sign: Novel Imaging Marker That Predicts Hematoma Growth in Patients With Intracerebral Hemorrhage. <i>Stroke.</i> 2016; <b>47</b>(7): 1777–81. <a target=xrefwindow id=d72507e2267 href="http://www.ncbi.nlm.nih.gov/pubmed/27174523">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2270 href="http://dx.doi.org/10.1161/STROKEAHA.116.013186">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726353955">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725571525"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e2283 class=n-a></a>Li Q, Zhang G, Huang YJ, <i> et al.</i>: Blend Sign on Computed Tomography: Novel and Reliable Predictor for Early Hematoma Growth in Patients With Intracerebral Hemorrhage. <i>Stroke.</i> 2015; <b>46</b>(8): 2119–23. <a target=xrefwindow id=d72507e2294 href="http://www.ncbi.nlm.nih.gov/pubmed/26089330">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2297 href="http://dx.doi.org/10.1161/STROKEAHA.115.009185">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725571525">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d72507e2310 class=n-a></a>Goldstein J, Brouwers H, Romero J, <i> et al.</i>: SCORE-IT: the Spot Sign score in restricting ICH growth─an Atach-II ancillary study. <i>J Vasc Interv Neurol.</i> 2012; <b>5</b>(supp): 20–5. <a target=xrefwindow id=d72507e2321 href="http://www.ncbi.nlm.nih.gov/pubmed/23230461">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2324 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3517028">Free Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d72507e2333 class=n-a></a>Menon RS, Burgess RE, Wing JJ, <i> et al.</i>: Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. <i>Ann Neurol.</i> 2012; <b>71</b>(2): 199–205. <a target=xrefwindow id=d72507e2344 href="http://www.ncbi.nlm.nih.gov/pubmed/22367992">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2347 href="http://dx.doi.org/10.1002/ana.22668">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2351 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3298034">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d72507e2361 class=n-a></a>Garg RK, Liebling SM, Maas MB, <i> et al.</i>: Blood pressure reduction, decreased diffusion on MRI, and outcomes after intracerebral hemorrhage. <i>Stroke.</i> 2012; <b>43</b>(1): 67–71. <a target=xrefwindow id=d72507e2372 href="http://www.ncbi.nlm.nih.gov/pubmed/21980211">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2375 href="http://dx.doi.org/10.1161/STROKEAHA.111.629493">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2379 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3246540">Free Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d72507e2388 class=n-a></a>Gregoire SM, Charidimou A, Gadapa N, <i> et al.</i>: Acute ischaemic brain lesions in intracerebral haemorrhage: multicentre cross-sectional magnetic resonance imaging study. <i>Brain.</i> 2011; <b>134</b>(Pt 8): 2376–86. <a target=xrefwindow id=d72507e2399 href="http://www.ncbi.nlm.nih.gov/pubmed/21841203">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2402 href="http://dx.doi.org/10.1093/brain/awr172">Publisher Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d72507e2411 class=n-a></a>Kimberly WT, Gilson A, Rost NS, <i> et al.</i>: Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. <i>Neurology.</i> 2009; <b>72</b>(14): 1230–5. <a target=xrefwindow id=d72507e2422 href="http://www.ncbi.nlm.nih.gov/pubmed/19349602">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2425 href="http://dx.doi.org/10.1212/01.wnl.0000345666.83318.03">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2429 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2677484">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d72507e2438 class=n-a></a>Prabhakaran S, Naidech AM: Ischemic brain injury after intracerebral hemorrhage: a critical review. <i>Stroke.</i> 2012; <b>43</b>(8): 2258–63. <a target=xrefwindow id=d72507e2446 href="http://www.ncbi.nlm.nih.gov/pubmed/22821611">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2449 href="http://dx.doi.org/10.1161/STROKEAHA.112.655910">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d72507e2458 class=n-a></a>Gioia L, Klahr A, Kate M, <i> et al.</i>: The intracerebral hemorrhage acutely decreasing arterial pressure trial II (ICH ADAPT II) protocol. <i>BMC Neurol.</i> 2017; <b>17</b>(1): 100. <a target=xrefwindow id=d72507e2469 href="http://www.ncbi.nlm.nih.gov/pubmed/28525977">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2472 href="http://dx.doi.org/10.1186/s12883-017-0884-4">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2476 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5437568">Free Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727244511"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e2485 class=n-a></a>Kidwell CS, Rosand J, Norato G, <i> et al.</i>: Ischemic lesions, blood pressure dysregulation, and poor outcomes in intracerebral hemorrhage. <i>Neurology.</i> 2017; <b>88</b>(8): 782–8. <a target=xrefwindow id=d72507e2496 href="http://www.ncbi.nlm.nih.gov/pubmed/28122903">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2499 href="http://dx.doi.org/10.1212/WNL.0000000000003630">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2503 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5344081">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727244511">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d72507e2517 class=n-a></a>Suri MF, Vazquez G, Ezzeddine MA, <i> et al.</i>: A multicenter comparison of outcomes associated with intravenous nitroprusside and nicardipine treatment among patients with intracerebral hemorrhage. <i>Neurocrit Care.</i> 2009; <b>11</b>(1): 50–5. <a target=xrefwindow id=d72507e2528 href="http://www.ncbi.nlm.nih.gov/pubmed/19224405">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2531 href="http://dx.doi.org/10.1007/s12028-009-9192-1">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2535 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5679130">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d72507e2544 class=n-a></a>Lahiri S, Nezhad M, Schlick KH, <i> et al.</i>: Paradoxical cerebrovascular hemodynamic changes with nicardipine. <i>J Neurosurg.</i> 2017; 1–5. <a target=xrefwindow id=d72507e2552 href="http://www.ncbi.nlm.nih.gov/pubmed/28430036">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2555 href="http://dx.doi.org/10.3171/2016.11.JNS161992">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a name=d72507e2564 class=n-a></a>Askenase MH, Sansing LH: Stages of the Inflammatory Response in Pathology and Tissue Repair after Intracerebral Hemorrhage. <i>Semin Neurol.</i> 2016; <b>36</b>(3): 288–97. <a target=xrefwindow id=d72507e2572 href="http://www.ncbi.nlm.nih.gov/pubmed/27214704">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2575 href="http://dx.doi.org/10.1055/s-0036-1582132">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2578 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4956485">Free Full Text </a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a name=d72507e2587 class=n-a></a>Sansing LH, Messe SR, Cucchiara BL, <i> et al.</i>: Anti-adrenergic medications and edema development after intracerebral hemorrhage. <i>Neurocrit Care.</i> 2011; <b>14</b>(3): 395–400. <a target=xrefwindow id=d72507e2598 href="http://www.ncbi.nlm.nih.gov/pubmed/21264527">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2601 href="http://dx.doi.org/10.1007/s12028-010-9498-z">Publisher Full Text </a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a name=d72507e2610 class=n-a></a>Shoup JP, Winkler J, Czap A, <i> et al.</i>: β-Blockers associated with no class-specific survival benefit in acute intracerebral hemorrhage. <i>J Neurol Sci.</i> 2014; <b>336</b>(1–2): 127–31. <a target=xrefwindow id=d72507e2621 href="http://www.ncbi.nlm.nih.gov/pubmed/24183854">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2624 href="http://dx.doi.org/10.1016/j.jns.2013.10.022">Publisher Full Text </a> | <a target=xrefwindow id=d72507e2628 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4956481">Free Full Text </a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d72507e2637 class=n-a></a>Manning L, Hirakawa Y, Arima H, <i> et al.</i>: Blood pressure variability and outcome after acute intracerebral haemorrhage: a post-hoc analysis of INTERACT2, a randomised controlled trial. <i>Lancet Neurol.</i> 2014; <b>13</b>(4): 364–73. <a target=xrefwindow id=d72507e2648 href="http://www.ncbi.nlm.nih.gov/pubmed/24530176">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2651 href="http://dx.doi.org/10.1016/S1474-4422(14)70018-3">Publisher Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d72507e2661 class=n-a></a>Lattanzi S, Cagnetti C, Provinciali L, <i> et al.</i>: Blood Pressure Variability and Clinical Outcome in Patients with Acute Intracerebral Hemorrhage. <i>J Stroke Cerebrovasc Dis.</i> 2015; <b>24</b>(7): 1493–9. <a target=xrefwindow id=d72507e2672 href="http://www.ncbi.nlm.nih.gov/pubmed/25873472">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2675 href="http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.03.014">Publisher Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727542168"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d72507e2684 class=n-a></a>Chang JJ, Khorchid Y, Dillard K, <i> et al.</i>: Elevated Pulse Pressure Levels Are Associated With Increased In-Hospital Mortality in Acute Spontaneous Intracerebral Hemorrhage. <i>Am J Hypertens.</i> 2017; <b>30</b>(7): 719–27. <a target=xrefwindow id=d72507e2695 href="http://www.ncbi.nlm.nih.gov/pubmed/28430838">PubMed Abstract </a> | <a target=xrefwindow id=d72507e2698 href="http://dx.doi.org/10.1093/ajh/hpx025">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727542168">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 21 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2035/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2035/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Neurology, Yale School of Medicine, New Haven, CT, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2035/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 21 Nov 2017, 6:2035 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.11687.1">https://doi.org/10.12688/f1000research.11687.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Chu S and Sansing L. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=12626 data-id=11687 data-downloads="" data-views="" data-scholar="10.12688/f1000research.11687.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2035/v1/pdf?article_uuid=81a7bcd9-d18b-4184-96df-7887704749f6" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.11687.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Chu S and Sansing L. Evolution of blood pressure management in acute intracerebral hemorrhage [version 1; peer review: 4 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2035 (<a href="https://doi.org/10.12688/f1000research.11687.1" target=_blank>https://doi.org/10.12688/f1000research.11687.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=11687 id=mobile-track-article-signin-11687 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/11687?target=/articles/6-2035/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=12626 /> <input name=articleId type=hidden value=11687 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>Michael L James</strong>, Departments of Anesthesiology and Neurology, Duke University School of Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Ken Butcher</strong>, University of Alberta, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> <span class=approved-referee__co-referee> <strong>Ana Klahr</strong>, University of Alberta, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Wendy Ziai</strong>, Department of Neurology, Johns Hopkins Medicine, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Craig Anderson</strong>, University of New South Wales, Australia </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 21 Nov 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2035/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2035/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=27980-27888></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=27978-27886></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=27979-27887></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=27981-27889></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=4><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> <th class="c-report-timeline__headings-version p-article__color--dark">4</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2035/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>21 Nov 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Michael L James</strong>, Departments of Anesthesiology and Neurology, Duke University School of Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Ken Butcher</strong>, University of Alberta, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> <p class=" u-mt--2 u-mb--1/2"><strong>Ana Klahr</strong>, University of Alberta, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Wendy Ziai</strong>, Department of Neurology, Johns Hopkins Medicine, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Craig Anderson</strong>, University of New South Wales, Australia </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2035/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2035/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Evolution of blood pressure management in...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2035/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2035/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2035/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Chu S and Sansing L');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2035/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2035",
            templates : {
                twitter : "Evolution of blood pressure management in acute intracerebral.... Chu S and Sansing L, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2035/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Evolution of blood pressure management in acute intracerebral hemorrhage", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Evolution of blood pressure management in acute intracerebral hemorrhage", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/11687/12626")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "12626");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "27888": 0,
                           "27889": 0,
                           "27886": 0,
                           "27887": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "b4837717-fc16-4dbc-acaa-994195f07341";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2035.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2035.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2035.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2035.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2035.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>